
James M. Silbermann
Examiner (ID: 13667)
| Most Active Art Unit | 1111 |
| Art Unit(s) | 1105, 1111, 1109 |
| Total Applications | 329 |
| Issued Applications | 248 |
| Pending Applications | 7 |
| Abandoned Applications | 74 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10749694
[patent_doc_number] => 20160095845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-07
[patent_title] => 'COMPOSITION COMPRISING (S)-(-)-BENPROPERINE FOR PREVENTING OR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/876509
[patent_app_country] => US
[patent_app_date] => 2015-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7203
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14876509
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/876509 | COMPOSITION COMPRISING (S)-(-)-BENPROPERINE FOR PREVENTING OR TREATING CANCER | Oct 5, 2015 | Abandoned |
Array
(
[id] => 11625831
[patent_doc_number] => 20170136021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING ENVELOPED VIRUSES'
[patent_app_type] => utility
[patent_app_number] => 14/873339
[patent_app_country] => US
[patent_app_date] => 2015-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16279
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14873339
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/873339 | METHODS AND COMPOSITIONS FOR TREATING ENVELOPED VIRUSES | Oct 1, 2015 | Abandoned |
Array
(
[id] => 12157255
[patent_doc_number] => 20180028520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/515679
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11995
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15515679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/515679 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | Sep 28, 2015 | Abandoned |
Array
(
[id] => 12183287
[patent_doc_number] => 20180042223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'COMPOSITION COMPRISING A HYDROGEL AND PESTICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/510729
[patent_app_country] => US
[patent_app_date] => 2015-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5408
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510729
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510729 | COMPOSITION COMPRISING A HYDROGEL AND PESTICIDES | Sep 14, 2015 | Abandoned |
Array
(
[id] => 10737238
[patent_doc_number] => 20160083388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'NOVEL MODULATORS OF NRF2 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/825481
[patent_app_country] => US
[patent_app_date] => 2015-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5249
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14825481
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/825481 | NOVEL MODULATORS OF NRF2 AND USES THEREOF | Aug 12, 2015 | Abandoned |
Array
(
[id] => 11864746
[patent_doc_number] => 20170232030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'COMBINATION THERAPY FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/503542
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 59110
[patent_no_of_claims] => 95
[patent_no_of_ind_claims] => 69
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503542
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503542 | COMBINATION THERAPY FOR TREATING CANCER | Aug 11, 2015 | Abandoned |
Array
(
[id] => 12580656
[patent_doc_number] => 20180085381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Adjunctive Therapy With 25-Hydroxyvitamin D
[patent_app_type] => utility
[patent_app_number] => 15/502498
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16308
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502498
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502498 | Adjunctive Therapy With 25-Hydroxyvitamin D | Aug 5, 2015 | Abandoned |
Array
(
[id] => 10450614
[patent_doc_number] => 20150335629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'Methods Of Treating Fragile X Syndrome And Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 14/819013
[patent_app_country] => US
[patent_app_date] => 2015-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12416
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14819013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/819013 | Methods Of Treating Fragile X Syndrome And Related Disorders | Aug 4, 2015 | Abandoned |
Array
(
[id] => 11954773
[patent_doc_number] => 20170258924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Ester of a Phospholipid With Conjugated Linoleic Acid for the Treatment of Psychiatric Disorders With Neuroinflammatory and Neurodegenerative Basis'
[patent_app_type] => utility
[patent_app_number] => 15/329968
[patent_app_country] => US
[patent_app_date] => 2015-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6631
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329968
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329968 | Ester of a Phospholipid With Conjugated Linoleic Acid for the Treatment of Psychiatric Disorders With Neuroinflammatory and Neurodegenerative Basis | Jul 26, 2015 | Abandoned |
Array
(
[id] => 11750285
[patent_doc_number] => 09708286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-18
[patent_title] => 'Ingenol-3-acylates III and ingenol-3-carbamates'
[patent_app_type] => utility
[patent_app_number] => 14/748925
[patent_app_country] => US
[patent_app_date] => 2015-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49067
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14748925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/748925 | Ingenol-3-acylates III and ingenol-3-carbamates | Jun 23, 2015 | Issued |
Array
(
[id] => 11588466
[patent_doc_number] => 20170112877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'NON-TOXIC AGENT FOR A BROAD-SPECTRUM, BACTERICIDAL OR BACTERIOSTATIC TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA IN ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 15/317616
[patent_app_country] => US
[patent_app_date] => 2015-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25976
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317616
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/317616 | NON-TOXIC AGENT FOR A BROAD-SPECTRUM, BACTERICIDAL OR BACTERIOSTATIC TREATMENT OF ANTIBIOTIC-RESISTANT BACTERIA IN ANIMALS | Jun 14, 2015 | Abandoned |
Array
(
[id] => 11567355
[patent_doc_number] => 20170105999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'METHOD FOR TREATING DRUG RESISTANT CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/316079
[patent_app_country] => US
[patent_app_date] => 2015-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6611
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316079
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316079 | METHOD FOR TREATING DRUG RESISTANT CANCER | Jun 1, 2015 | Abandoned |
Array
(
[id] => 10669562
[patent_doc_number] => 20160015707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'METHOD OF PROMOTING REMYELINATION'
[patent_app_type] => utility
[patent_app_number] => 14/723008
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 23354
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14723008
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/723008 | Method of promoting remyelination | May 26, 2015 | Issued |
Array
(
[id] => 10669562
[patent_doc_number] => 20160015707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'METHOD OF PROMOTING REMYELINATION'
[patent_app_type] => utility
[patent_app_number] => 14/723008
[patent_app_country] => US
[patent_app_date] => 2015-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 23354
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14723008
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/723008 | Method of promoting remyelination | May 26, 2015 | Issued |
Array
(
[id] => 11602394
[patent_doc_number] => 20170119694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'SKIN CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/360084
[patent_app_country] => US
[patent_app_date] => 2015-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6561
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15360084
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/360084 | Skin cancer treatment | May 25, 2015 | Issued |
Array
(
[id] => 11742915
[patent_doc_number] => 20170196987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'METHODS FOR TREATING MULTIPLE SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 15/313955
[patent_app_country] => US
[patent_app_date] => 2015-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3705
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313955
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/313955 | METHODS FOR TREATING MULTIPLE SCLEROSIS | May 20, 2015 | Abandoned |
Array
(
[id] => 11527181
[patent_doc_number] => 20170087159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'PLATELET-DERIVED GROWTH FACTOR RECEPTOR MUTATIONS AND COMPOSITIONS AND METHODS RELATING THERETO'
[patent_app_type] => utility
[patent_app_number] => 15/311582
[patent_app_country] => US
[patent_app_date] => 2015-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 22864
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311582
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/311582 | Platelet-derived growth factor receptor mutations and compositions and methods relating thereto | May 14, 2015 | Issued |
Array
(
[id] => 10489818
[patent_doc_number] => 20150374839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 14/692918
[patent_app_country] => US
[patent_app_date] => 2015-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 6718
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14692918
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/692918 | NOVEL FATTY ACID-SALICYLATE CONJUGATES WITH ENHANCED THERAPEUTIC PROPERTIES | Apr 21, 2015 | Abandoned |
Array
(
[id] => 11441865
[patent_doc_number] => 20170042887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 15/305782
[patent_app_country] => US
[patent_app_date] => 2015-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6841
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15305782
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/305782 | Combination of Brexpiprazole and Nalmefene and Use Thereof for Treating Substance-Related Disorders | Apr 21, 2015 | Abandoned |
Array
(
[id] => 10421049
[patent_doc_number] => 20150306057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'METHOD FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER\'S TYPE'
[patent_app_type] => utility
[patent_app_number] => 14/674705
[patent_app_country] => US
[patent_app_date] => 2015-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 33278
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14674705
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/674705 | Method for the treatment of senile dementia of the Alzheimer's type | Mar 30, 2015 | Issued |